Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

被引:399
作者
Begriche, Karima [2 ]
Massart, Julie [1 ]
Robin, Marie-Anne [1 ]
Borgne-Sanchez, Annie [3 ]
Fromenty, Bernard [1 ]
机构
[1] INSERM, U991, F-35043 Rennes, France
[2] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA
[3] Hop Robert Debre, Mitol SAS, F-75019 Paris, France
关键词
Hepatotoxicity; Drugs; Mitochondria; Steatosis; Lipids; Cell death; Obesity; Oxidative stress; FATTY-ACID OXIDATION; PROLIFERATOR-ACTIVATED RECEPTOR; DNA-POLYMERASE-GAMMA; PREGNANE X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; MANGANESE SUPEROXIDE-DISMUTASE; TRIGLYCERIDE TRANSFER PROTEIN; HEPATIC CYTOCHROME-P450 2E1; STRESS-RELATED PARAMETERS; ELEMENT-BINDING PROTEINS;
D O I
10.1016/j.jhep.2010.11.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Numerous investigations have shown that mitochondrial dysfunction is a major mechanism of drug-induced liver injury, which involves the parent drug or a reactive metabolite generated through cytochromes P450. Depending of their nature and their severity, the mitochondrial alterations are able to induce mild to fulminant hepatic cytolysis and steatosis (lipid accumulation), which can have different clinical and pathological features. Microvesicular steatosis, a potentially severe liver lesion usually associated with liver failure and profound hypoglycemia, is due to a major inhibition of mitochondrial fatty acid oxidation (FAO). Macrovacuolar steatosis, a relatively benign liver lesion in the short term, can be induced not only by a moderate reduction of mitochondrial FAO but also by an increased hepatic de nova lipid synthesis and a decreased secretion of VLDL-associated triglycerides. Moreover, recent investigations suggest that some drugs could favor lipid deposition in the liver through primary alterations of white adipose tissue (WAT) homeostasis. if the treatment is not interrupted, steatosis can evolve toward steatohepatitis, which is characterized not only by lipid accumulation but also by necroinflammation and fibrosis. Although the mechanisms involved in this aggravation are not fully characterized, it appears that overproduction of reactive oxygen species by the damaged mitochondria could play a salient role. Numerous factors could favor drug-induced mitochondrial and metabolic toxicity, such as the structure of the parent molecule, genetic predispositions (in particular those involving mitochondrial enzymes), alcohol intoxication, hepatitis virus C infection, and obesity. In obese and diabetic patients, some drugs may induce acute liver injury more frequently while others may worsen the pre-existent steatosis (or steatohepatitis). (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:773 / 794
页数:22
相关论文
共 350 条
[81]  
DESCHAMPS D, 1991, J PHARMACOL EXP THER, V259, P894
[82]   INHIBITION BY PERHEXILINE OF OXIDATIVE-PHOSPHORYLATION AND THE BETA-OXIDATION OF FATTY-ACIDS - POSSIBLE ROLE IN PSEUDOALCOHOLIC LIVER-LESIONS [J].
DESCHAMPS, D ;
DEBECO, V ;
FISCH, C ;
FROMENTY, B ;
GUILLOUZO, A ;
PESSAYRE, D .
HEPATOLOGY, 1994, 19 (04) :948-961
[83]   PPAR-mediated activity of phthalates: A link to the obesity epidemic? [J].
Desvergne, Beatrice ;
Feige, Jerome N. ;
Casals-Casas, Cristina .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 304 (1-2) :43-48
[84]   A CaPful of mechanisms regulating the mitochondrial permeability transition [J].
Di Lisa, Fabio ;
Bernardi, Paolo .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (06) :775-780
[85]   Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction [J].
Diamond, Deborah L. ;
Jacobs, Jon M. ;
Paeper, Bryan ;
Proll, Sean C. ;
Gritsenko, Marina A. ;
Carithers, Robert L., Jr. ;
Larson, Aflne M. ;
Yeh, Matthew M. ;
Camp, David G., II ;
Smith, Richard D. ;
Katze, Michael G. .
HEPATOLOGY, 2007, 46 (03) :649-657
[86]  
Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
[87]   Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies [J].
Dixit, Rakesh ;
Boelsterli, Urs A. .
DRUG DISCOVERY TODAY, 2007, 12 (7-8) :336-342
[88]   Salicylic acid-induced hepatotoxicity triggered by oxidative stress [J].
Doi, Hirokazu ;
Horie, Toshiharu .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 183 (03) :363-368
[89]   Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease [J].
Dong, Bingning ;
Saha, Pradip K. ;
Huang, Wendong ;
Chen, Wenling ;
Abu-Elheiga, Lutfi A. ;
Wakil, Salih J. ;
Stevens, Robert D. ;
Ilkayeva, Olga ;
Newgard, Christopher B. ;
Chan, Lawrence ;
Moore, David D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) :18831-18836
[90]  
Dong Z, 1997, AM J PATHOL, V151, P1205